Timely ED Pain Care Linked to Relief in Terminal Cancer Cohort

11/09/2026
Key Takeaways
- Among adults with terminal cancer presenting with pain to an emergency department in China, more than half had effective short-term relief after analgesia.
- Prompt pain assessment, analgesic administration, and documented reassessment each had significant adjusted associations with relief.
- Patients classified as meeting all three documented timing criteria had significantly more effective relief than those classified as missing at least one criterion.
- The group classified as meeting all three criteria also had shorter emergency stays and fewer 72-hour revisits.
In a retrospective cohort, researchers reviewed records for 724 adults presenting primarily with pain to a tertiary hospital in Luzhou, China, from January 1, 2017, through December 31, 2023. Eligibility required oncologist-documented terminal cancer and complete clinical and nursing records; exclusions included death within 30 minutes, no initial pain score, or impaired communication without a caregiver proxy. Effective relief meant a decrease of at least two points on the numeric rating scale (NRS) within one hour after the first analgesic dose. The authors classified 286 patients as meeting a post hoc three-step workflow—documented initial assessment and first analgesic administration within 30 minutes of arrival and reassessment within one hour of that dose—and 438 patients as missing at least one step. However, their reported analgesia-timing data conflict with that classification, so adherence in the groups is unclear. Forward-stepwise multivariable logistic regression assessed individual factors, while unadjusted chi-square and t tests compared the groups.
Across the full cohort, 58.2% achieved effective relief. First analgesic administration within 30 minutes was significantly associated with relief after adjustment, with an odds ratio (OR) of 2.24 (95% confidence interval [CI] 1.57–3.21). Timely initial assessment, documented reassessment, and opioid use also had significant adjusted associations with relief.
In the unadjusted post hoc comparison, effective relief occurred in 75.9% of patients classified as meeting all three timing criteria versus 46.6% of those classified as missing at least one, a statistically significant difference. The group classified as meeting all three criteria also had faster relief, shorter ED stays, and fewer revisits within 72 hours. These group differences were not randomized treatment effects.
Retrospective, nonrandomized grouping limits causal interpretation: initial pain severity differed between groups, workflow steps may be interdependent, and residual confounding is possible. Incomplete-record exclusions, potentially inaccurate timestamps, and the absence of formal sensitivity analyses add uncertainty. Patients without documented ED analgesia remained in the full cohort, complicating interpretation of an outcome timed from the first dose. Self-reported pain scores may be less reliable when consciousness fluctuates. Findings from one well-resourced center in China do not establish applicability to U.S. EDs. Although opioid use was associated with relief, unavailable dosing, titration, rescue-treatment, and adverse-effect data preclude conclusions about drug-class superiority or safety.
Recorded timely assessment, analgesic administration, and reassessment coincided with better short-term pain relief in this cohort. The investigators called for prospective studies to determine whether changing workflow causes better outcomes.
Clinician Questions
How was terminal cancer defined for adults evaluated for emergency-department pain relief?
Terminal cancer meant oncologist-confirmed incurable malignancy with progressive clinical deterioration, or stage IV cancer in a patient receiving palliative care.
Did emergency-department terminal-cancer pain outcomes include patient satisfaction or end-of-life preferences?
Nie and colleagues evaluated pain-score relief and short-term emergency-care outcomes but did not assess patient satisfaction, caregiver perspectives on care, or alignment with end-of-life preferences.
This content is intended for healthcare professionals for educational purposes. The article and its image were developed with AI assistance and reviewed by members of the ReachMD team prior to publication. Please refer to the original source linked for the complete and most up-to-date information.
